Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

BACKGROUND: The prognostic utility of systemic inflammatory markers has so far not been investigated in patients with metastatic testicular germ cell tumours (GCTs). METHODS: International Germ Cell Cancer Cooperative Group (IGCCCG) risk groups and blood-based systemic inflammatory markers (haemoglo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Cancer
Glavni autori: Fankhauser, Christian Daniel, Sander, Sophia, Roth, Lisa, Gross, Oliver, Eberli, Daniel, Sulser, Tullio, Seifert, Burkhardt, Beyer, Joerg, Hermanns, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2018
Teme:
Translational Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5877429/
https://ncbi.nlm.nih.gov/pubmed/29485982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.467
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items